ARTICLE | Clinical News
TherMax topical dermatan sulfate: Began Phase II trial
July 5, 1994 7:00 AM UTC
CytRx Corp. (CYTR), Atlanta Product: TherMax topical dermatan sulfate, a component of the skin matrix Indication: Pain and itching in burn wound healing Status: Began Phase II trial in 40 patients; an...